Drug Shortage Report for ACT SERTRALINE
Report ID | 3343 |
Drug Identification Number | 02287390 |
Brand name | ACT SERTRALINE |
Common or Proper name | SERTRALINE |
Company Name | ACTAVIS PHARMA COMPANY |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | SERTRALINE |
Strength(s) | 25MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | N06AB |
ATC description | ANTIDEPRESSANTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2017-03-17 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2018-12-20 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2017-10-10 | French | Compare |
v4 | 2017-10-10 | English | Compare |
v3 | 2017-03-18 | English | Compare |
v2 | 2017-03-17 | French | Compare |
v1 | 2017-03-17 | English | Compare |
Showing 1 to 5 of 5